About Index Trending news
Analyze
Pricing
Chimerix

Chimerix

Work at Chimerix? Add yourself to this profile

Chimerix

Developing important antiviral medicines for the treatment of life-threatening diseases. $CMRX
Edit Profile
More info

Elsewhere

Companies in the same industry

NestSense NestSense Lysosomal Therapeutics Lysosomal Therapeutics BioVentrix BioVentrix Medigus Medigus Lifecode, Inc. Lifecode, Inc. Jazz Pharmaceuticals Jazz Pharmaceuticals Eleven Biotherapeutics Eleven Biotherapeutics REACH Health REACH Health Takeda Pharmaceutical Company Ltd Takeda Pharmaceutical Company Ltd NuscriptRX NuscriptRX

Alexa global traffic share

Twitter followers

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 5
Add info
07 Nov 2014
$122,000,000
Post-IPO equity
14 Feb 2011
$45,000,000
Venture capital (Series F)
Alta Partners, New Leaf Venture Partners, Pappas Ventures
10 Aug 2009
$16,100,000
Venture capital (Series E)
Canaan Partners, Asset Management Ventures (AMV), Asset Management Company, +1
23 Feb 2007
$23,100,000
Venture capital (Series D)
Sanderling Ventures, Frazier Healthcare Partners, Asset Management Company
04 Nov 2004
$11,000,000
Venture capital (Series C)
Asset Management Ventures (AMV), Frazier Technology Ventures, Asset Management Company